Atlas Trials

Combination of Irinotecan and Temozolomide in Children With Brain Tumors.

Clinical trial NCT00404495 · COMPLETED

Trial details

NCT number
NCT00404495
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GliomaMedulloblastoma
Start date
2007-04-01
Primary completion
2011-01-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.